Subscribe To
Terns Pharmaceuticals to Participate in Upcoming Investor Conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity, today announced that members of management will be participating in the following upcoming investor conferences: […] The post Terns Pharmaceuticals to Participate in Upcomin...
Read More
Posted: Oct 19 2023, 20:05
Author Name: forextv
Views: 082363